✦ LIBER ✦

PMH52 Levomilnacipran in the Treatment of Major Depressive Disorder: Functional Health and Well-Being Efficacy Results from a Phase III Clinical Trial

✍ Scribed by S.I. Blum; S. Tourkodimitris; A. Ruth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.022 Levomilnacipran in the treatme

✍ S. Blum; S. Tourkodimitris; A. Ruth; J. Terner-Rosenthal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

P.2.c.020 The efficacy and safety of lev

✍ A. Bose; C. Chen; C. Gommoll; A. Ruth; J. Terner-Rosenthal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

P.2.c.021 Levomilnacipran in the treatme

✍ W. Greenberg; C. Gommoll; A. Bose; H. Li; A. Ruth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P.2.c.006 Efficacy and clinical relevanc

✍ A. Khan; W. Song; J. Edwards; A. Ruth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Efficacy of bupropion and the selective

✍ George I. Papakostas; Madhukar H. Trivedi; Jonathan E. Alpert; Cheryl A. Seifert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Efficacy and safety of bexarotene combin

✍ S. Whittaker; P. Ortiz; R. Dummer; A. Ranki; B. Hasan; B. Meulemans; S. Gellrich 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB